Double PIK3CA mutations in cis enhance oncogene activation and sensitivity to PI3K alpha inhibitors in breast cancer Meeting Abstract


Authors: Vasan, N.; Razavi, P.; Johnson, J.; Shao, H.; Shah, H.; Antoine, A.; Ladewig, E.; Gorelick, A.; Toska, E.; Xu, G.; Kazmi, A.; Chang, M. T.; Taylor, B. S.; Dickler, M. N.; Jhaveri, K.; Rabadan, R.; Reznik, E.; Smith, M. L.; Sebra, R.; Cantley, L. C.; Scaltriti, M.; Baselga, J.
Abstract Title: Double PIK3CA mutations in cis enhance oncogene activation and sensitivity to PI3K alpha inhibitors in breast cancer
Meeting Title: 110th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 79
Issue: 13 Suppl.
Meeting Dates: 2019 Mar 29-Apr 3
Meeting Location: Atlanta, GA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2019-07-01
Language: English
ACCESSION: WOS:000488279403316
DOI: 10.1158/1538-7445.Am2019-3917
PROVIDER: wos
Notes: Meeting Abstract: 3917 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Komal Lachhman Jhaveri
    201 Jhaveri
  2. Barry Stephen Taylor
    238 Taylor
  3. Erik Manfred Ladewig
    16 Ladewig
  4. Maurizio Scaltriti
    169 Scaltriti
  5. Eduard Reznik
    103 Reznik
  6. Pedram Razavi
    172 Razavi
  7. Eneda   Toska
    30 Toska
  8. Neil Vasan
    19 Vasan
  9. Guotai Xu
    14 Xu
  10. Hong Shao
    11 Shao
  11. Abiha Kazmi
    4 Kazmi